AIM ImmunoTech Inc

XASE:AIM 4:00:00 PM EDT

0.24

-0.01 (-2.59%)

7:59:08 PM EDT: $0.23 -0.01 (-3.04%)

Market Cap (Intraday)	3.37M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.01 Million
Adjusted EPS	-$0.53

See more estimates

10-Day MA	$0.30
50-Day MA	$0.54
200-Day MA	$1.47

See more pivots

AIM ImmunoTech Inc Stock, XASE:AIM

2117 South West Highway 484, 2117 SW Highway 484, Ocala, Florida 34473

United States of America

Phone: +1.352.448.7797

Number of Employees: 26

http://www.aimimmuno.com

Description

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.